Keywords: vectura, licenses, copd, drugs, sandoz, uk-based, pulmonary

Vectura licenses COPD drugs to Sandoz

Article | 15 September 2008

Print This

UK-based pulmonary drug developer Vectura has licensed to Sandoz, the generics division of Swiss drug major Novartis, the exclusive rights ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in